Related Articles
Sorafenib combined with gemcitabine in EGFR‑TKI‑resistant human lung cancer cells
Combination treatment of gemcitabine and sorafenib exerts a synergistic inhibitory effect on non‑small cell lung cancer in vitro and in vivo via the epithelial‑to‑mesenchymal transition process
Synergistic interaction between sorafenib and gemcitabine in EGFR‑TKI‑sensitive and EGFR‑TKI‑resistant human lung cancer cell lines
Combined RNAi targeting human Stat3 and ADAM9 as gene therapy for non‑small cell lung cancer Retraction in /10.3892/ol.2022.13595
Combining sorafenib with celecoxib synergistically inhibits tumor growth of non-small cell lung cancer cells in vitro and in vivo